OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
Turnover
87.07%
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$3.17B
AUM Growth
-$433M
(-12%)
Cap. Flow
-$475M
Cap. Flow
% of AUM
-14.97%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
659
New
65
Increased
74
Reduced
444
Closed
67
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$23.6M |
| 2 |
Comcast
CMCSA
|
+$15.2M |
| 3 |
McCormick & Company Non-Voting
MKC
|
+$15M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$14.1M |
| 5 |
Amgen
AMGN
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$25.1M |
| 2 |
UnitedHealth
UNH
|
+$24.3M |
| 3 |
Walgreens Boots Alliance
WBA
|
+$18.8M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$18.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.91% |
| 2 | Healthcare | 15.49% |
| 3 | Technology | 14.4% |
| 4 | Energy | 10.51% |
| 5 | Consumer Staples | 10.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $88.6M | 2.8% |
4,623,416
-553,700
| -11% | -$10.5M |
2013 Q2
3 quarters
|
|
|
2
ExxonMobil
XOM
$728B
| $72M | 2.27% |
736,607
+247,215
| +51% | +$23.6M |
2013 Q2
3 quarters
|
|
|
3
Alphabet (Google) Class C
GOOG
$4.2T
| $69.8M | 2.2% |
2,514,430
-589,601
| -19% | -$17.2M |
2013 Q2
3 quarters
|
|
4
JPMorgan Chase
JPM
$890B
| $62.9M | 1.98% |
1,036,178
-147,179
| -12% | -$8.51M |
2013 Q2
3 quarters
|
|
5
Procter & Gamble
PG
$364B
| $61M | 1.93% |
757,350
-133,484
| -15% | -$10.5M |
2013 Q2
3 quarters
|
|
6
Microsoft
MSFT
$3.96T
| $60M | 1.89% |
1,464,025
-329,400
| -18% | -$12.4M |
2013 Q2
3 quarters
|
|
7
Johnson & Johnson
JNJ
$612B
| $56.8M | 1.79% |
578,591
-134,379
| -19% | -$12.5M |
2013 Q2
3 quarters
|
|
8
Oracle
ORCL
$396B
| $49.4M | 1.56% |
1,207,965
-42,120
| -3% | -$1.6M |
2013 Q2
3 quarters
|
|
|
9
Chevron
CVX
$436B
| $46.7M | 1.47% |
392,386
-216,126
| -36% | -$25.1M |
2013 Q2
3 quarters
|
|
10
PepsiCo
PEP
$176B
| $46.6M | 1.47% |
558,237
-96,107
| -15% | -$7.8M |
2013 Q2
3 quarters
|
|
11
Pfizer
PFE
$166B
| $44.9M | 1.42% |
1,473,707
-386,506
| -21% | -$11.5M |
2013 Q2
3 quarters
|
|
12
Wells Fargo
WFC
$243B
| $42.7M | 1.35% |
858,238
-167,879
| -16% | -$7.82M |
2013 Q2
3 quarters
|
|
13
Citigroup
C
$205B
| $41.6M | 1.31% |
874,006
+210,059
| +32% | +$10.5M |
2013 Q2
3 quarters
|
|
14
Merck
MRK
$364B
| $38.5M | 1.22% |
711,300
-201,281
| -22% | -$10.4M |
2013 Q2
3 quarters
|
|
15
Berkshire Hathaway Class B
BRK.B
$1.13T
| $38.2M | 1.2% |
305,489
-55,239
| -15% | -$6.45M |
2013 Q2
3 quarters
|
|
16
SLB Ltd
SLB
$72B
| $36.9M | 1.16% |
378,228
-35,875
| -9% | -$3.25M |
2013 Q2
3 quarters
|
|
17
Medtronic
MDT
$121B
| $35.9M | 1.13% |
582,810
-63,435
| -10% | -$3.7M |
2013 Q2
3 quarters
|
|
18
American Express
AXP
$207B
| $35.3M | 1.11% |
392,460
-36,895
| -9% | -$3.3M |
2013 Q2
3 quarters
|
|
19
Nike
NKE
$52.4B
| $35M | 1.1% |
947,140
+168,930
| +22% | +$6.38M |
2013 Q2
3 quarters
|
|
20
Amazon
AMZN
$2.74T
| $34.6M | 1.09% |
2,057,180
-280,000
| -12% | -$5.2M |
2013 Q2
3 quarters
|
|
21
Coca-Cola
KO
$395B
| $33.2M | 1.05% |
859,484
+153,650
| +22% | +$5.94M |
2013 Q2
3 quarters
|
|
22
GE Aerospace
GE
$319B
| $33.2M | 1.05% |
267,180
-43,746
| -14% | -$5.4M |
2013 Q2
3 quarters
|
|
23
Bank of America
BAC
$359B
| $32.6M | 1.03% |
1,897,812
-413,559
| -18% | -$6.96M |
2013 Q2
3 quarters
|
|
24
Walt Disney
DIS
$188B
| $31.7M | 1% |
396,497
-19,090
| -5% | -$1.48M |
2013 Q2
3 quarters
|
|
25
Cisco
CSCO
$448B
| $31.3M | 0.99% |
1,397,756
-60,548
| -4% | -$1.34M |
2013 Q2
3 quarters
|
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q1 2014 Portfolio in Review
As of Q1 2014, Oakbrook Investments held 659 positions worth $3.17B, down 12% from $3.6B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Oakbrook Investments withdrew a net $475M in Q1 2014, closing 67 positions and reducing 444 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $18.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Oakbrook Investments opened a new position in McCormick & Company Non-Voting worth $16M.
- Oakbrook Investments's largest Q1 2014 buy was McCormick & Company Non-Voting: 445,890 shares worth $16M.
- Oakbrook Investments added most to ExxonMobil in Q1 2014, an estimated $23.6M increase.
- Oakbrook Investments's biggest Q1 2014 reduction was Chevron, cutting an estimated $25.1M.
- Oakbrook Investments fully exited Express Scripts Holding Company in Q1 2014, selling an estimated $18.4M.
- Oakbrook Investments's ten largest holdings make up 19% of its $3.17B portfolio in Q1 2014.
- Oakbrook Investments opened 65 new positions and closed 67 in Q1 2014.
- Oakbrook Investments's portfolio value fell 12% quarter-over-quarter to $3.17B.
Based on Oakbrook Investments's 13F filing for Q1 2014, filed 17 Apr 2014.